Effects of an over-the-counter lactic-acid containing intra-vaginal douching product on the vaginal microbiota

[1]  J. Ravel,et al.  Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid , 2018, mSphere.

[2]  J. H. van de Wijgert,et al.  The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands , 2017, PloS one.

[3]  R. Cone,et al.  The role of lactic acid production by probiotic Lactobacillus species in vaginal health. , 2017, Research in microbiology.

[4]  D. Anderson,et al.  Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition , 2017, Mucosal Immunology.

[5]  Jennifer M. Fettweis,et al.  Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. , 2017, Contraception.

[6]  M. Henriques,et al.  Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors , 2016, Critical reviews in microbiology.

[7]  S. Bruisten,et al.  The Cervicovaginal Microbiota in Women Notified for Chlamydia trachomatis Infection: A Case-Control Study at the Sexually Transmitted Infection Outpatient Clinic in Amsterdam, The Netherlands , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  G. Hung,et al.  Development of Candida-Specific Real-Time PCR Assays for the Detection and Identification of Eight Medically Important Candida Species , 2016, Microbiology insights.

[9]  S. Delany-Moretlwe,et al.  The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women , 2015, BMC Infectious Diseases.

[10]  P. Gajer,et al.  An effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women. , 2014, AIDS research and human retroviruses.

[11]  Jennifer M. Fettweis,et al.  Differences in vaginal microbiome in African American women versus women of European ancestry. , 2014, Microbiology.

[12]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[13]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[14]  J. Wijgert,et al.  Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women , 2014, The ISME Journal.

[15]  P. Gajer,et al.  An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform , 2014, Microbiome.

[16]  L. Forney,et al.  Influence of Vaginal Bacteria and d- and l-Lactic Acid Isomers on Vaginal Extracellular Matrix Metalloproteinase Inducer: Implications for Protection against Upper Genital Tract Infections , 2013, mBio.

[17]  R. Cone,et al.  Vaginal concentrations of lactic acid potently inactivate HIV , 2013, The Journal of antimicrobial chemotherapy.

[18]  Z. Abdo,et al.  Effects of tampons and menses on the composition and diversity of vaginal microbial communities over time , 2013, BJOG : an international journal of obstetrics and gynaecology.

[19]  R. Fichorova,et al.  Effects of feminine hygiene products on the vaginal mucosal biome , 2013, Microbial ecology in health and disease.

[20]  M. Vaneechoutte,et al.  Longitudinal qPCR Study of the Dynamics of L. crispatus, L. iners, A. vaginae, (Sialidase Positive) G. vaginalis, and P. bivia in the Vagina , 2012, PloS one.

[21]  Jeanne M. Marrazzo,et al.  Bacterial Communities in Women with Bacterial Vaginosis: High Resolution Phylogenetic Analyses Reveal Relationships of Microbiota to Clinical Criteria , 2012, PloS one.

[22]  J. Menten,et al.  Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests , 2012, BMC Microbiology.

[23]  Zaid Abdo,et al.  Temporal Dynamics of the Human Vaginal Microbiota , 2012, Science Translational Medicine.

[24]  Andre P. Masella,et al.  PANDAseq: paired-end assembler for illumina sequences , 2012, BMC Bioinformatics.

[25]  R. Cone,et al.  In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide , 2011, BMC infectious diseases.

[26]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[27]  C. Morrison,et al.  Intravaginal Practices, Bacterial Vaginosis, and HIV Infection in Women: Individual Participant Data Meta-analysis , 2011, PLoS medicine.

[28]  R. Brotman,et al.  Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. , 2010, The Journal of infectious diseases.

[29]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[30]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[31]  J. Marrazzo,et al.  Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis , 2010, PloS one.

[32]  E. Virginia Armbrust,et al.  pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree , 2010, BMC Bioinformatics.

[33]  R. Brotman,et al.  Personal Hygienic Behaviors and Bacterial Vaginosis , 2010, Sexually transmitted diseases.

[34]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[35]  G. Doncel,et al.  Six-Day Randomized Safety Trial of Intravaginal Lime Juice , 2008, Journal of acquired immune deficiency syndromes.

[36]  D. Scharfstein,et al.  A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. , 2008, American journal of epidemiology.

[37]  D. Scharfstein,et al.  The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. , 2008, American journal of obstetrics and gynecology.

[38]  J. Baeten,et al.  A Prospective Study of Risk Factors for Bacterial Vaginosis in HIV-1-Seronegative African Women , 2008, Sexually transmitted diseases.

[39]  K. Whaley,et al.  Lime juice as a candidate microbicide? An open-label safety trial of 10% and 20% lime juice used vaginally. , 2007, Journal of women's health.

[40]  R. Ness,et al.  Vaginal Douching and Development of Bacterial Vaginosis Among Women With Normal and Abnormal Vaginal Microflora , 2007, Sexually transmitted diseases.

[41]  Wiley Interscience,et al.  Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey , 2007, Journal of medical virology.

[42]  R. Brotman,et al.  A Pilot Study of Vaginal Flora Changes With Randomization to Cessation of Douching , 2006, Sexually transmitted diseases.

[43]  R. Cone,et al.  Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission , 2006, BMC infectious diseases.

[44]  C. S. Padolina,et al.  Metronidazole with Lactacyd vaginal gel in bacterial vaginosis , 2006, The journal of obstetrics and gynaecology research.

[45]  S. Asavapiriyanont,et al.  Satisfaction and tolerability of combination of lactoserum and lactic acid on the external genitalia in Thai women. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[46]  S. Garland,et al.  Higher-Risk Behavioral Practices Associated With Bacterial Vaginosis Compared With Vaginal Candidiasis , 2005, Obstetrics and gynecology.

[47]  R. Desmond,et al.  Predictors of Bacterial Vaginosis in Adolescent Women Who Douche , 2004, Sexually transmitted diseases.

[48]  S. Vermund,et al.  Vaginal douching: evidence for risks or benefits to women's health. , 2002, Epidemiologic reviews.

[49]  C. Holzman,et al.  Factors linked to bacterial vaginosis in nonpregnant women. , 2001, American journal of public health.

[50]  A. Meier,et al.  Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  J. H. van de Wijgert,et al.  Effect of Intravaginal Practices on the Vaginal and Cervical Mucosa of Zimbabwean Women , 2000, Journal of acquired immune deficiency syndromes.

[52]  B. Chohan,et al.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. , 1999, The Journal of infectious diseases.

[53]  J. Schwebke,et al.  Correlation of behaviors with microbiological changes in vaginal flora. , 1999, The Journal of infectious diseases.

[54]  N. Low,et al.  Bacterial vaginosis, ethnicity, and the use of genital cleaning agents: a case control study. , 1999, Sexually transmitted diseases.

[55]  M A Krohn,et al.  The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  P. Kostense,et al.  Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial. , 1993, Genitourinary medicine.

[57]  M. Delaney,et al.  Quantitative and Qualitative Effects of Douche Preparations on Vaginal Microflora , 1992, Obstetrics and gynecology.

[58]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.

[59]  H. Baer,et al.  Quantitative and qualitative effects of povidone-iodine liquid and gel on the aerobic and anaerobic flora of the female genital tract. , 1980, American journal of obstetrics and gynecology.

[60]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[61]  Li Tao,et al.  In vitro inhibition of commercial douche products against vaginal microflora. , 2000, Infectious diseases in obstetrics and gynecology.